Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profiles
Early antibody therapy can prevent severe SARS-CoV-2 infection (COVID-19). However, the effectiveness of COVID-19 convalescent plasma (CCP) therapy in treating severe COVID-19 remains inconclusive. To test a hypothesis that some CCP units are associated with a coagulopathy hazard in severe disease t...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Clinical Investigation
2025-05-01
|
| Seri Bilgileri: | The Journal of Clinical Investigation |
| Konular: | |
| Online Erişim: | https://doi.org/10.1172/JCI181136 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
